Drug Manufacturing Innovation Act of 2022

United States117th CongressHR-6988House of Representatives
Updated: Mar 9, 2022

Summary

Drug Manufacturing Innovation Act of 2022 This bill requires the Food and Drug Administration to establish a program to support innovative approaches to pharmaceutical product design and manufacturing, including through grants, regulatory guidance, and working groups.

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

  1. Referred to the House Committee on Energy and Commerce.

    House of Representatives

  2. Introduced in House

  3. Referred to the Subcommittee on Health.

    House of Representatives

All available records shown.